Cabozantinib after prior checkpoint inhibitor therapy in patients with solid tumors: A systematic literature review
Journal
Cancer treatment reviews
Journal Volume
110
Date Issued
2022-11
Author(s)
Abstract
We conducted a systematic literature review to identify evidence for cabozantinib activity in patients with solid tumors after prior checkpoint inhibitor (CPI) therapy.
Subjects
Cabozantinib; Checkpoint inhibitors; Hepatocellular carcinoma; Immunotherapy; Non-small cell lung cancer; Renal cell carcinoma; Tyrosine kinase inhibitor
SDGs
Publisher
ELSEVIER SCI LTD
Type
review